Thus, in this study, we showed evidence that platelets are increased in DS-TB patients; moreover, these patients can be divided into groups with inflammatory or angiogenic factors, suggesting that PF4 and VEGF-A levels are determinants of the clinical status of DS-TB. This evidence concerns the gene PF4 and tuberculosis.